Earnings Ahead

OMER - Omeros Corporation

2.7 0.17 6.72

Omeros Corporation

Omeros Corporation

About

Profile


Headquarters

Seattle, Washington, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

OMER



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Omeros Non-GAAP EPS of -$0.37 misses by $0.31
  • Omeros Q4 2021 Earnings Preview
  • Omeros responds to Complete Response Letter on narsoplimab for kidney damage
  • Omeros could trade as a pure-play biotech after divesting Omidria - Cantor
  • ICE Biotech index rejig: AUPH, AVXL among added; AMRS, GH among deleted
  • Omeros to sell OMIDRIA franchise to Rayner Surgical for more than $1B
  • Top 10 deletions from the MSCI US Investable Market 2500 Index during semi-annual rejig
  • Omeros EPS beats by $0.01, beats on revenue
  • Omeros Q3 2021 Earnings Preview
  • Omeros' long term data of phase 2 trial of narsoplimab shows benefit in kidney disorder
  • Valneva SE, MeiraGTx leads healthcare gainers; Revance Therapeutics, Omeros aming major losers
  • Omeros shares slide 18% after FDA fails to approve narsoplimab treatment
  • Hot Stocks: F, TTM deal rumors; TTWO release; RPTX clarifies data; OMER downgrade; IMOS misses revenue
  • Omeros' rough start to October continues as shares down ~24%
  • Omeros slips 11% on JPMorgan downgrade, analyst anticipates CRL
  • Omeros continues decline on deficiencies with narsoplimab BLA, analyst downgrades
  • Xenon Pharmaceuticals, Milestone Scientific leads healthcare gainers; Owlet, REGENXBIO among major losers
  • Atea Pharma, Evolent among weekly healthcare gainers; Omeros, Novavax trail
  • Progenity, Biomerica leads healthcare gainers; Omeros, Adagio Therapeutics among major losers
  • Omeros suffers setback in U.S. marketing application for narsoplimab
Date Price Open High Low Vol ER
Sep 2 4.51 4.40
4.72
4.20
668.15K
Sep 1 4.36 3.95
4.36
3.80
472.75K
Aug 31 4.03 3.70
4.12
3.70
341.02K
Aug 30 3.73 3.75
3.87
3.66
320.10K
Aug 29 3.76 3.75
3.94
3.71
466.72K
 
Aug 26 3.82 3.96
4.04
3.79
532.88K
Aug 25 3.93 4.40
4.41
3.87
870.88K
Aug 24 4.32 4.80
4.91
4.31
801.16K
Aug 23 4.79 5.17
5.37
4.78
865.01K
Aug 22 5.13 5.69
5.87
5.09
921.84K
Aug 19 5.87 5.96
6.15
5.80
420.95K